Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
11h
Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
Retiring after 15 seasons
School shooting report
Republicans appeal ruling
Sells for $9M at auction
Donations drop 15%
PG&E shuts off power
Dow closes at record high
Musk's first Trump event
School shooting indictment
La Nina could arrive soon
NYC giant pigeon sculpture
Three Americans detained
TX top court halts execution
Sued for alleged misconduct
US charges ex-Indian spy
Eases voting rules
‘Full Self-Driving’ probe
Teen tobacco use falls
Afghan man denied release
Nevada US Senate debate
988 Lifeline georouting
OK classroom Bible suit
Space export curbs eased
Teen anti-sextortion push
Calif. oil refinery closure
Delphi trial begins
At decade-high level
Feedback